| Literature DB >> 36076855 |
Juraj Deglovic1, Nora Majtanova2, Juraj Majtan3,4.
Abstract
The successful application of honey in wound care management has been achieved due to honey's potent antibacterial effects, characterised by its multifactorial action. Impressive clinical efficacy has ignited its further use in diverse clinical disciplines, including stomatology. Indeed, there is increasing usage of honey in dental medicine as a preventive or therapeutic remedy for some periodontal diseases mainly associated with bacteria, such as dental caries, gingivitis and mucositides. Dental caries is undoubtedly a major oral health problem worldwide, with an increasing tendency of incidence. The purpose of this perspective review is to describe the recent progress in the laboratory and clinical use of honey in the prevention of dental caries, with emphasis on the antibacterial and antibiofilm effects of honey. The role of honey in the cariogenic process is also discussed. In addition, the quality of honey and the urgent in vitro evaluation of its antibacterial/antibiofilm properties before clinical use are highlighted. Findings based on data extracted from laboratory studies demonstrate the pronounced antibacterial effect of different honeys against a number of periodontal pathogens, including Streptococcus mutans. Although the promising antibiofilm effects of honey have been reported mainly against S. mutans, these results are limited to very few studies. From a clinical point of view, honey significantly reduces dental plaque; however, it is not superior to the conventional agent. Despite the positive in vitro results, the clinical effectiveness of honey in the prevention of dental caries remains inconclusive since further robust clinical studies are needed.Entities:
Keywords: S. mutans; antibacterial; dental medicine; honey; quality
Year: 2022 PMID: 36076855 PMCID: PMC9455747 DOI: 10.3390/foods11172670
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Dominant antibacterial constituents of honey and their mechanisms of action against oral bacteria.
| Antibacterial Factor/Compound | Origin | Target Bacteria | Mechanism of Action | Ref. | |
|---|---|---|---|---|---|
| Gram-Positive | Gram-Negative | ||||
| MRJP1 | bee | + * | + * | Disruption of cell wall integrity * | [ |
| defensin-1 | bee | + | + | Decreased bacterial cell hydrophobicity and disruption of cell membrane permeability | [ |
| H2O2 | bee | + | + | Destruction of cell wall integrity. Lipid peroxidation and damage to bacterial cell proteins and DNA | [ |
| gluconic acid | bee | - | + | Membrane depolarisation and destruction | [ |
| MGO | plant | + | + | Oxidative stress by reacting with cellular proteins and DNA | [ |
* Reported antibacterial activity remains controversial.
Figure 1A schematic overview of the most dominant biological effects of honey in the prevention of dental caries.
Summary of data collected from human clinical studies using honey as an anti-plaque agent.
| Type of Honey | Honey Concentration | Honey Sterility | Control | Participants | Outcomes | Year | Ref. |
|---|---|---|---|---|---|---|---|
| MH UMF 15+ | 100% | No | 0.2% CHX | MH group (n = 15) | In a pilot clinical study, MH was able to significantly reduce the plaque score after a 21-day trial period. On the other hand, no significant changes were observed in the control group. | 2004 | [ |
| MH | 100% | No | 0.2% CHX | MH group (n = 20) | In a single-blind study, MH and chlorhexidine mouthwash significantly reduced plaque formation in comparison to xylitol chewing gum after 3 days of use. | 2010 | [ |
| Multifloral | 50% | No | 0.2% CHX | Honey group | In a double-masked parallel clinical trial based on a 4-day plaque regrowth model, honey, although less potent than chlorhexidine, reduced plaque formation. | 2012 | [ |
| Unspecified honey | 100% | No | 10% sucrose | n = 20 * | Significant differences in plaque pH were shown between the honey and sucrose groups compared to the sorbitol group. Among the mouthwashes tested, only honey was able to significantly reduce the number of bacteria that were recovered from plaques 30 min after exposure. | 2014 | [ |
| Unspecified honey | 100% | No | 0.2% CHX | Honey group | In a single-blind randomised control trial, all groups were effective in reducing plaque. The honey group was more effective than the CHX group but comparable with the CHX + xylitol group over periods of 15 and 30 days. | 2015 | [ |
| Tongra honey | 5% | No | None- | Honey group | A significant difference was shown between dental plaque scores before and after using honey as a mouthwash for a period of 6 days. | 2018 | [ |
| MH | 40% (MH) | No | 0.2% CHX | MH group (n = 45) | All tested mouthwashes showed significant reductions in plaque scores. CHX was most effective in reducing plaque. No differences in efficacy were documented between MH and RH. | 2018 | [ |
| Unspecified honey | 50% | No | 0.12% CHX | Honey group (n=20) | All tested mouthwashes showed an immediate and direct reduction of | 2021 | [ |
| MH UMF 15+ | 100% | No | 0.2% CHX | MH group (n = 30) | In a randomised controlled trial, no significant differences in plaque score and | 2021 | [ |
MH, manuka honey; RH, raw honey; CHX, chlorhexidine gluconate; UMF, unique manuka factor. * Number of subjects in therapeutic groups was not shown.